These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31088833)

  • 1. Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic Reovirus.
    Kennedy BE; Murphy JP; Clements DR; Konda P; Holay N; Kim Y; Pathak GP; Giacomantonio MA; Hiani YE; Gujar S
    Cancer Res; 2019 Aug; 79(15):3824-3836. PubMed ID: 31088833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.
    Mohamed A; Johnston RN; Shmulevitz M
    Viruses; 2015 Dec; 7(12):6251-78. PubMed ID: 26633466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma.
    Lawson KA; Mostafa AA; Shi ZQ; Spurrell J; Chen W; Kawakami J; Gratton K; Thakur S; Morris DG
    Clin Cancer Res; 2016 Dec; 22(23):5839-5850. PubMed ID: 27220962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells loaded with oncolytic reovirus enhances antitumor activity in mice models of colorectal cancer.
    Babaei A; Soleimanjahi H; Soleimani M; Arefian E
    Biochem Pharmacol; 2021 Aug; 190():114644. PubMed ID: 34090878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy.
    Kennedy BE; Sadek M; Gujar SA
    Mol Ther; 2020 Jun; 28(6):1417-1421. PubMed ID: 32243836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors.
    Rodríguez Stewart RM; Berry JTL; Berger AK; Yoon SB; Hirsch AL; Guberman JA; Patel NB; Tharp GK; Bosinger SE; Mainou BA
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reovirus and tumor oncolysis.
    Kim M; Chung YH; Johnston RN
    J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
    Shmulevitz M; Lee PW
    Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reovirus as a viable therapeutic option for the treatment of multiple myeloma.
    Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
    Clin Cancer Res; 2012 Sep; 18(18):4962-72. PubMed ID: 22761466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency
    Mohamed A; Clements DR; Gujar SA; Lee PW; Smiley JR; Shmulevitz M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy.
    Kumar V; Giacomantonio MA; Gujar S
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33920168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.
    Kaplon J; Zheng L; Meissl K; Chaneton B; Selivanov VA; Mackay G; van der Burg SH; Verdegaal EM; Cascante M; Shlomi T; Gottlieb E; Peeper DS
    Nature; 2013 Jun; 498(7452):109-12. PubMed ID: 23685455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic reovirus effectively targets breast cancer stem cells.
    Marcato P; Dean CA; Giacomantonio CA; Lee PW
    Mol Ther; 2009 Jun; 17(6):972-9. PubMed ID: 19293772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma.
    Kennedy BE; Giacomantonio M; Murphy JP; Cutler S; Sadek M; Konda P; Paulo JA; Pathak GP; Renkens SHJ; Grieve S; Pol J; Gygi SP; Richardson C; Gaston D; Reiman A; Kroemer G; Elnenaei MO; Gujar SA
    Mol Ther Oncolytics; 2022 Mar; 24():695-706. PubMed ID: 35284625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus.
    Zhao X; Ouyang W; Chester C; Long S; Wang N; He Z
    PLoS One; 2017; 12(9):e0184816. PubMed ID: 28922411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replication.
    Prestwich RJ; Ilett EJ; Errington F; Diaz RM; Steele LP; Kottke T; Thompson J; Galivo F; Harrington KJ; Pandha HS; Selby PJ; Vile RG; Melcher AA
    Clin Cancer Res; 2009 Jul; 15(13):4374-4381. PubMed ID: 19509134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic Viral Therapy Using Reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2015; 1317():187-223. PubMed ID: 26072409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small extracellular vesicles carrying reovirus, tumor antigens, interferon-β, and damage-associated molecular patterns for efficient tumor treatment.
    Shuwari N; Inoue C; Ishigami I; Jingushi K; Kamiya M; Kawakami S; Tsujikawa K; Tachibana M; Mizuguchi H; Sakurai F
    J Control Release; 2024 Oct; 374():89-102. PubMed ID: 39122217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
    Heinemann L; Simpson GR; Boxall A; Kottke T; Relph KL; Vile R; Melcher A; Prestwich R; Harrington KJ; Morgan R; Pandha HS
    BMC Cancer; 2011 Jun; 11():221. PubMed ID: 21645351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche.
    Müller LME; Migneco G; Scott GB; Down J; King S; Askar B; Jennings V; Oyajobi B; Scott K; West E; Ralph C; Samson A; Ilett EJ; Muthana M; Coffey M; Melcher A; Parrish C; Cook G; Lawson M; Errington-Mais F
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.